Cellular Plasticity–Targeted Therapy in Head and Neck Cancers. (June 2018)

• Record Type: Journal Article
• Authors: Shang, W.; Zhang, Q.; Huang, Y.; Shanti, R.; Alawi, F.; Le, A.; Jiang, C.
• Other Names: Nör J.E. guest-editor.; Gutkind J.S. guest-editor.
• Is Part Of: Journal of dental research. Volume 97:Number 6(2018)
• Page Start: 654
• Page End: 664
• Publication Date: 2018-06
• Subjects: cancer microenvironment -- cancer stem cells -- epithelial-mesenchymal transition -- hypoxia -- epigenetics -- metastasis; Dentistry -- Periodicals; Dentistry -- Social aspects -- Periodicals; Dentistry -- Periodicals; Research -- Periodicals; 617.6005
• DOI: 10.1177/0022034518756351
• Languages: English
• ISSNs: 0022-0345

Abstract

Head and neck cancer is one of the most frequent human malignancies worldwide, with a high rate of recurrence and metastasis. Head and neck squamous cell carcinoma (HNSCC) is cellularly and molecularly heterogeneous, with subsets of undifferentiated cancer cells exhibiting stem cell-like properties, called cancer stem cells (CSCs). Epithelial-mesenchymal transition, gene mutation, and epigenetic modification are associated with the formation of cellular plasticity of tumor cells in HNSCC, contributing to the acquisition of invasive, recurrent, and metastatic properties and therapeutic resistance. Tumor microenvironment (TME) plays a supportive role in the initiation, progression, and metastasis of head and neck cancer. Stromal fibroblasts, vasculature, immune cells, cytokines, and hypoxia constitute the main components of TME in HNSCC, which contributes not only to the acquisition of CSC properties but also to the recurrence and therapeutic resistance of the malignancies. In this review, we discuss the potential mechanisms underlying the development of cellular plasticity, especially the emergence of CSCs, in HNSCC. We also highlight recent studies implicating the complex interplays among TME components, plastic CSCs, tumorigenesis, recurrence, and therapeutic resistance of HNSCC. Finally, we summarize the treatment modalities of HNSCC and reinforce the novel concept of therapeutic targeting CSCs in HNSCC.